Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amiloride/spironolactone - Hemodynamic Therapeutics

Drug Profile

Amiloride/spironolactone - Hemodynamic Therapeutics

Alternative Names: amiloride hydrochloride/spironolactone; HTI-101; spironolactone/amiloride; spironolactone/amiloride-hydrochloride

Latest Information Update: 14 Sep 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Alabama
  • Class Antihormones; Antihypertensives; Lactones; Pregnenes; Pyrazines; Small molecules
  • Mechanism of Action Aldosterone antagonists; Potassium-sparing diuretics; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Resistant hypertension

Most Recent Events

  • 14 Sep 2017 Chemical structure information added
  • 03 Aug 2015 No recent reports on development identified - Phase-II for Resistant hypertension in USA (PO)
  • 14 Dec 2009 HTI 101 is available for collaboration for development and commercialisation (http://www.hemodynamictx.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top